相关实验视频

Updated: May 5, 2026

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Published on: September 26, 2010

预测胰腺癌的预后和治疗反应中的ALDH家族的作用

Xing Wu¹, Bolin Zhang¹, Yijun Chen²

¹Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, University Medical Center Halle, 06120 Halle (Saale), Germany.

|August 28, 2025

概括

这项研究确定了关键的脱酶 (ALDH) 基因,与胰腺癌存活率和化疗反应有关. 了解ALDH基因表达为胰腺癌预后和治疗策略提供了新的见解.

科学领域:

癌症学
生物化学
遗传学

背景情况:

胰腺癌是美国癌症死亡的主要原因.
甲基脱酶 (ALDH) 基因家族在癌症预后和治疗耐药性方面发挥作用.
特定的ALDH基因与胰腺癌结局的关联尚不清楚.

研究的目的:

研究ALDH基因家族成员在胰腺癌中的预后意义.
探索ALDH基因表达,瘤微环境和化疗敏感性之间的关系.
确定胰腺腺癌 (PAAD) 的潜在基于ALDH的生物标志物.

主要方法:

利用癌症基因组图谱 (TCGA) 和基因型-组织表达 (GTEx) 项目的转录和临床数据.
进行Kaplan-Meier分析进行预后评估,KEGG/GO进行途径分析,ESTIMATE进行瘤微环境评估.
使用CIBERSORT,免疫透分析和OncoPredict进行化疗敏感性预测.

主要成果:

确定了四个与PAAD预后有显著关联的ALDH基因 (ALDH1L1,ALDH3A1,ALDH3B1,ALDH5A1).
高表达的ALDH1L1,ALDH3A1和ALDH3B1与较短的整体存活时间相关;ALDH5A1与较长的存活时间相关.
与KRAS突变状态相关的ALDH3A1表达,较低的免疫细胞透,以及对帕克利塔塞尔的敏感性增加.

结论:

特定的ALDH家族成员作为胰腺癌的关键预后指标.
ALDH基因表达影响瘤微环境和化疗反应.
这些发现突显了ALDH基因作为胰腺癌治疗的生物标志物的临床实用性.

关键词:

ALDH家族生物标志物化学电阻免疫透胰腺癌

更多相关视频

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity

Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity

Published on: March 31, 2023

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...